tandospirone

Subscribe to Selected New Research on tandospirone

59 relevant articles (14 outcomes, 13 trials/studies) found for this Bio-Agent

Description: structure given in first source

Also Known As:

3a,4,7,7a-hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-4,7-methano-1H-isoindole-1,3(2H)-dione; SM 3997; SM-3997; 4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, (3aalpha,4beta,7beta,7aalpha)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 25

1-Ring Heterocyclic Compounds

2-Ring Heterocyclic Compounds

Isoindoles

tandospirone: 59

Experts

1.	Yamashita, I: 3 articles (10/2001 - 06/2000)
2.	Meltzer, H Y: 3 articles (10/2001 - 06/2000)
3.	Sumiyoshi, T: 3 articles (10/2001 - 06/2000)
4.	Nohara, S: 3 articles (10/2001 - 06/2000)
5.	Matsui, M: 3 articles (10/2001 - 06/2000)
6.	Kurachi, M: 3 articles (10/2001 - 06/2000)
7.	Murata, Tetsuhito: 2 articles (03/2008 - 01/2008)
8.	Takahashi, Tetsuya: 2 articles (03/2008 - 01/2008)
9.	Wada, Yuji: 2 articles (03/2008 - 01/2008)
10.	Fukazawa, Toshiyuki: 2 articles (12/2003 - 04/2002)

Related Diseases

1.	Dyskinesias (Dyskinesia) 12/01/1998 - "The authors examined the effect of tandospirone on tardive dyskinesia (TD) and parkinsonian symptoms in an open study. " 02/01/2002 - "Diverse effect of tandospirone may be caused by its partial agonist activity on 5-HT1A receptors, or may indicate that other causes for the expression of dyskinesia exist apart from excessive rise in brain DA levels. " 02/01/2002 - "Twelve weeks after tandospirone treatment, duration of dyskinesia, subjective and objective severity of dyskinesia, and parkinsonian features were evaluated. " 12/01/1998 - "Effect of tandospirone on tardive dyskinesia and parkinsonian symptoms." 02/01/2002 - "The present study demonstrated that tandospirone is effective in alleviating L-DOPA-induced dyskinesia in 50% of the patients. " Order ALL the reference details at left...
2.	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 02/01/2001 - "[A case of progressive supranuclear palsy improved with tandospirone citrate]" 01/01/2002 - "[Clinical effectiveness of tandospirone citrate (5-HT1A agonist) on patients with progressive supranuclear palsy]" 11/01/2000 - "[Effects of tandospirone citrate on frozen gait in patients with early stage of progressive supranuclear palsy, investigated by walk-induced activation single photon emission computed tomography method]" 11/01/2000 - "We reported a 64-year-old woman in the early stage of progressive supranuclear palsy presenting as pure akinesia syndrome who showed marked improvement with tandospirone citrate. " 02/01/2001 - "We reported a 74-year-old male case of progressive supranuclear palsy (PSP) who responded to tandospirone citrate, a serotonin receptor (5-HT1A) agonist. " Order ALL the reference details at left...
3.	Postoperative Nausea and Vomiting (PONV) 11/01/2002 - "We have hypothesized that the 5-hydroxytrypta-mine-1A receptor agonist tandospirone reduces postoperative nausea and vomiting (PONV). " 11/01/2002 - "IMPLICATIONS: Oral tandospirone reduced the incidence of postoperative nausea and vomiting without significant adverse effects in adults undergoing tympanoplasty under general anesthesia." 11/01/2002 - "In conclusion, premedication with oral tandospirone is effective against PONV in patients undergoing tympanoplasty under general anesthesia. " 09/01/2008 - "The available nontraditional antiemetics that have been shown to be effective for the prophylaxis against PONV are propofol, dexamethasone, tandospirone, and midazolam. " Order ALL the reference details at left...
4.	Syndrome 05/01/1993 - "Substitution of vehicle for tandospirone after 7 weeks produced time-limited suppression of food intake, suggesting a mild withdrawal syndrome. " 04/01/1997 - "Furthermore, tandospirone has been reported to show a significantly more superior or equipotent effect to diazepam in controlling autonomic disturbances, psychiatric cardiovascular and vegetative syndromes as well as neurosis in double blind clinical studies. " 06/01/1993 - "When administered by injection, tandospirone blocked the production of the 5-HT syndrome 1 hr (drug present), but not 24 hr (drug absent), following either 1 day or 14 days of drug treatment. " 06/01/1993 - "The infusion of tandospirone blocked elicitation of the 5-HT behavioral syndrome when tested after 1 or 14 days of drug treatment (drug present) and 24 hr after the drug was withdrawn (drug absent). " 05/01/1992 - "Furthermore, this destruction altered neither the effect of tandospirone on punished responding in this procedure nor the potency of tandospirone to induce a flat body posture in rats, which is known as the "serotonin behavioral syndrome". " Order ALL the reference details at left...
5.	Dyspepsia (Indigestion) 11/01/2009 - "Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial." 06/01/2005 - "Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia." 06/01/2005 - "PATIENTS AND METHODS: Sixty-four functional dyspepsia patients without Helicobacter pylori infection were randomly assigned to 15 mg/day of mosapride, 40 mg/day of famotidine, or 30 mg/day of tandospirone during an 8-week treatment. " 01/01/2008 - "Mosapride was as effective as famotidine and itopride, but more effective than tandospirone, in improving overall or individual symptoms of functional dyspepsia in randomized trials. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Citric Acid (Citrate)
2.	Levodopa (L Dopa)
3.	Buspirone (Buspar)
4.	Paroxetine (Paxil)
5.	Propofol (Diprivan)
6.	Midazolam (Versed)
7.	Dexamethasone (Maxidex)
8.	Clomipramine (Anafranil)
9.	Antiemetics
10.	Antipsychotic Agents (Antipsychotics)

Related Therapies and Procedures

1.	Tympanoplasty
2.	Premedication
3.	General Anesthesia

Best Treatments:
Research Summary Report
on Dyskinesias

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 595 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>